Skip to main content
. 2022 Jan 25;8:5. doi: 10.1038/s41421-021-00368-w

Fig. 6. Anti-proliferative effects and signaling inhibition of TH-Z835 on non-KRAS(G12D) cells.

Fig. 6

a Cell viability assays of 4T1, MIA PaCa-2, CFPAC-1, and HCT116 cells with indicated concentration of TH-Z835 for 24 h, 72 h, or 120 h in 2D adherent assays (upper panel) and 3D non-adherent assays plates (lower panel). b Immunoblotting of EGFR, ERK, AKT phosphorylation, and cPARP in 4T1, MIA PaCa-2, CFPAC-1, and HCT116 cells treated with TH-Z835 for 3 h.